Licensing Analysis

Eli Lilly pipeline and deals: GLP-1, vaccines, and 2026 outlook

diabetes · 7 min

McGuireWoods' Alyssa Campbell Honored in M&A Advisor Emerging Leaders Awards

5 min

Otsuka kidney drug data and Pfizer AI deal: Biopharma deal tracker

IgA nephropathy · 8 min

China: The Innovation Factor – Implications for Pharma BD and Investors

6 min

Utah Medical Board Scolded for Going Rogue with AI Criticism: Deal Implications for Pharma

6 min

Mercury Acquires King Courier to Grow Bay Area Logistics: Deal Intelligence for Pharma Teams

5 min

Best Biotech News Sources: How Legend Biotech Emerged as a Rare Market Winner

6 min

House bill aims to crack down on China biotech deals

5 min

ASCO Summit: Ivonescimab's China Lung Data Shows Promise, But Global Validation Remains Key

lung · 8 min

STAT+ R&D Performance Ranking: Insights for Pharma Companies

FDA · 7 min

TrumpRx's Generic Drug Expansion: Strategic Implications for the Pharmaceutical Industry

FDA · 8 min

Eli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases

genetic kidney diseases · 7 min